UBS Group AG - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$150,000
-85.6%
4,429
-90.1%
0.00%
Q1 2021$1,045,000
+2650.0%
44,697
+3278.5%
0.00%
Q4 2020$38,0001,323
+16437.5%
0.00%
Q2 2020$0
-100.0%
8
-99.7%
0.00%
Q1 2020$83,000
-87.3%
2,649
-80.9%
0.00%
Q4 2019$655,000
+750.6%
13,905
+15.9%
0.00%
Q3 2019$77,000
+126.5%
11,993
+329.5%
0.00%
Q2 2019$34,000
+325.0%
2,792
+40.7%
0.00%
Q4 2018$8,000
-11.1%
1,985
+56.1%
0.00%
Q3 2018$9,0001,2720.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders